Document Detail


Clinical use of immunosuppressive drugs: part II.
MedLine Citation:
PMID:  1278059     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In haematological diseases, insufficient data has been accumulated to evaluate the efficacy of immunosuppressive drug treatment in patients with erythroid aplasia or sideroblastic anaemia. Cyclophosphamide may be efficacious in inhibiting circulating anticoagulants in patients who need continued replacement of clotting factors. Azathioprine, 6-mercaptopurine, cyclophosphamide and vincristine have been used successfully in treating patients with idiopathic thrombocytopenic purpura, and some patients with auto-immune haemolytic anaemia may benefit from the addition of purine analogues. However, the use of immunosuppressive therapy seems to accelerate the presence of haematological malignancies in patients with macroglobulinaemia. In gastro-intestinal diseases, uncontrolled studies have shown nitrogen mustard, 6-mercaptopurine and azathioprine to be of modest benefit to patients with ulcerative colitis and Crohn's disease. In a controlled trial azathioprine plus prednisone proved more effective than prednisone alone in sustaining remission in patients with Crohn's disease. In patients with either chronic active hepatitis or primary biliary cirrhosis, however, there seems to be no benefit from immunosuppressive therapy for primary treatment of these diseases. Cyclophosphamide, azathioprine and methotrexate have all been used with some success in treating patient with uveitis, and in a controlled trial cytarabine has been shown to be beneficial to patients with herpes ophthalmicus. However, no benefit has been shown to patients with the eye changes of Graves' disease with either azathioprine or methotrexate. Patients with Paget's disease appear to be helped by mithramycin. Cyclophosphamide, chlorambucil and azathioprine are ineffective in treating patients with multiple sclerosis. 6-Mercaptopurine, azathioprine, methotrexate and cyclophosphamide have all produced some benefit in patients with myasthenia gravis, and some patients with idiopathic pulmonary haemosiderosis have responded to azathioprine, 6-mercaptopurine and cyclophosphamide. Alkylating agents have proved useful in treating some patients with asthma and in treating frequent relapsers among children with the nephrotic syndrome. In adults with membrano-proliferative glomerulonephritis some patients have responded to combination therapy with cyclophosphamide, azathioprine and corticosteroids. Immunosuppressive therapy is also indicated in prolonging graft survivals in patients receiving organ transplants. Drug toxicities of immunosuppressive agents are discussed. Their long-term effects, including mutagenic potential, have as yet not been fully elucidated.
Authors:
N L Gerber; A D Steinberg
Related Documents :
6229579 - Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation wi...
6402089 - Hla antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia ...
7697959 - D-penicillamine induced myasthenia gravis in rheumatoid arthritis: an unpredictable com...
1973409 - Different hla dr-dq associations in subgroups of idiopathic myasthenia gravis.
17522949 - The role of malignancies in patients with catastrophic anti-phospholipid (asherson's) s...
16367899 - Irreversible cochlear damage in myasthenia gravis -- otoacoustic emission analysis.
3172849 - Mediastinal mass and tracheal obstruction during general anesthesia.
17828809 - Stimulating erythropoiesis in inflammatory bowel disease associated anemia.
19736169 - Changes in white matter microstructure in patients with tle and hippocampal sclerosis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Drugs     Volume:  11     ISSN:  0012-6667     ISO Abbreviation:  Drugs     Publication Date:  1976  
Date Detail:
Created Date:  1976-09-01     Completed Date:  1976-09-01     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7600076     Medline TA:  Drugs     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  90-112     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amyloidosis / drug therapy
Drug Interactions
Eye Diseases / drug therapy
Gastrointestinal Diseases / drug therapy
Graft Rejection / drug therapy
Hematologic Diseases / drug therapy
Humans
Immunosuppressive Agents / adverse effects,  therapeutic use*
Kidney Diseases / drug therapy
Liver Diseases / drug therapy
Lung Diseases / drug therapy
Neuromuscular Diseases / drug therapy
Osteitis Deformans / drug therapy
Chemical
Reg. No./Substance:
0/Immunosuppressive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Allergic agranulocytosis due to promethazine
Next Document:  The prevalence of hypertension in the United States today.